Akari Therapeutics to Attend Upcoming Investor Conferences in February

NEW YORK and LONDON, January 31st, 2017

Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that senior management will attend and host meetings at two upcoming conferences.

• Canaccord Genuity 2017 Rare Disease, Biopharma One-on-One Day on Tuesday, February 7, 2017 in New York, NY
• Leerink Partners 6th Annual Global Healthcare Conference on February 16, 2017 in New York, NY

Click here to see full release